Long-Term NSAID Use Has a Relation to Lower Dementia Hazard

Summary: A recent study indicates that a lower risk of dementia is associated with long-term use of non-steroidal anti-inflammatory drugs ( NSAIDs ). Researchers studied 11, 745 adults over the course of 14.5 years to discover that those who long-term used NSAIDs had a 12 % lower dementia risk.

Nonetheless, the overall combined injection and short- and intermediate-term NSAID apply did not have the same impact. These results point to the possibility that long-term anti-inflammatory effects may aid in memory prevention.

Important Information

    Long-term use of NSAIDs results in a 12 % lower dementia risk.

  • Short-Term Use: No notable safe effect was observed.
  • Findings help inflammation’s role in the progression of dementia.

Origin: Wiley

Previous research has suggested that inflammation may play a role in dementia’s development and progression, and that non-steroidal anti-inflammatory ( NSAID ) medications may assist in dementia prevention because of their anti-inflammatory effects.

Long-term use of NSAIDs was linked to a 12 % lower risk of dementia. Rewards were not found for short- and long-term usage. Neuroscience News deserves funds.

A brand-new, large-scale possible study, published in the Journal of the American Geriatrics Society, provides more proof that long-term NSAID usage is associated with a reduced risk of dementia.

In the population-based review of 11, 745 people with an ordinary follow-up of 14.5 times, 9, 520 individuals used NSAIDs at any given time, and 2, 091 members died from memory. Long-term use of NSAIDs was linked to a 12 % lower risk of dementia. Rewards were not found for short- and long-term usage.

Additionally, NSAIDs alone did not have a role in reducing memory danger.

The results point to the possibility that using anti-inflammatory medications for a long time more than for a long time may help prevent memory.

” Our study provides evidence on potential preventive consequences of anti-inflammatory medications against the memory process.

More studies are required to further strengthen this evidence and develop preventive measures, according to Erasmus MC University Medical Center Rotterdam’s ( N ) corresponding author M. Arfan Ikram, MD, PhD, M. Arfan Ikram, MD, PhD.

About this information about neuropharmacology and memory research

Publisher: Sara Henning-Stout
Source: Wiley
Contact: Sara Henning-Stout – Wiley
Image: The image is credited to Neuroscience News

Original Research: The results will be published in the Journal of the American Geriatrics Society.


Share This Post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Do You Want To Boost Your Business?

drop us a line and keep in touch

[ihc-register]